A detailed history of Duff & Phelps Investment Management CO transactions in Amgen Inc stock. As of the latest transaction made, Duff & Phelps Investment Management CO holds 6,170 shares of AMGN stock, worth $1.92 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,170
Previous 5,941 3.85%
Holding current value
$1.92 Million
Previous $1.71 Million 2.51%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$268.87 - $324.56 $61,571 - $74,324
229 Added 3.85%
6,170 $1.75 Million
Q4 2023

Feb 05, 2024

BUY
$255.7 - $288.46 $8,949 - $10,096
35 Added 0.59%
5,941 $1.71 Million
Q3 2023

Nov 13, 2023

BUY
$218.65 - $271.46 $22,302 - $27,688
102 Added 1.76%
5,906 $1.59 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $77,214 - $87,083
-344 Reduced 5.6%
5,804 $1.31 Million
Q4 2021

Feb 07, 2022

BUY
$198.88 - $227.6 $5,170 - $5,917
26 Added 0.42%
6,148 $1.38 Million
Q3 2021

Nov 10, 2021

SELL
$212.27 - $248.7 $31,415 - $36,807
-148 Reduced 2.36%
6,122 $1.3 Million
Q2 2021

Aug 09, 2021

SELL
$233.58 - $259.14 $131,972 - $146,414
-565 Reduced 8.27%
6,270 $1.53 Million
Q1 2021

May 10, 2021

SELL
$221.91 - $258.6 $22,191 - $25,860
-100 Reduced 1.44%
6,835 $1.7 Million
Q2 2020

Aug 06, 2020

BUY
$197.81 - $242.74 $23,737 - $29,128
120 Added 1.76%
6,935 $1.64 Million
Q3 2018

Oct 22, 2018

SELL
$185.29 - $208.89 $125,997 - $142,045
-680 Reduced 9.07%
6,815 $1.41 Million
Q2 2018

Aug 02, 2018

SELL
$166.05 - $186.51 $51,475 - $57,818
-310 Reduced 3.97%
7,495 $1.38 Million
Q1 2018

May 01, 2018

SELL
$169.43 - $198.0 $35,580 - $41,580
-210 Reduced 2.62%
7,805 $1.33 Million
Q4 2017

Jan 24, 2018

SELL
$168.79 - $188.59 $31,226 - $34,889
-185 Reduced 2.26%
8,015 $1.39 Million
Q3 2017

Oct 25, 2017

BUY
$167.29 - $191.0 $1.37 Million - $1.57 Million
8,200
8,200 $1.53 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Duff & Phelps Investment Management CO Portfolio

Follow Duff & Phelps Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duff & Phelps Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Duff & Phelps Investment Management CO with notifications on news.